Eye Unit, University Hospitals Southampton NHS Foundation Trust
Southampton, SO16 6YD, United Kingdom
NCT Number: NCT05169983
A visual field (VF) is a measurement of how wide an area our eyes can see when fixed onto a point. Visual field testing is one of the ways of assessing how much vision there is in each eye and how much vision might have been lost over time. Defects in the visual field are seen in diseases such as glaucoma, which is one of the leading causes of blindness. VF tests should be performed regularly during outpatient appointments to help monitor these conditions before they progress. Monitoring individuals with VF defects presents a large strain on eye services at University Hospitals Southampton (UHS).
Recently an Apple iPad-based application called 'VisualFields easy' has been developed that could be used at home to test visual fields, opening up the possibility of remote monitoring. This is especially significant since the onset of the COVID-19 pandemic which has left outpatient clinics across the UK with large patient backlogs. However, it's not understood yet to what level of accuracy this iPad test can be performed by untrained people and whether the results of this test are medically reliable.
This study will measure if there's a correlation between iPad-based VF measurements and the standard clinic-based measurements taken by professionals. The potential of this app to be used at home will also be assessed with a usability questionnaire. These measurements will be taken during routine eye and neurology outpatient clinics at UHS. Home-based VF testing could allow those who weren't able to access eye services during the pandemic greater follow-up and monitoring. Through providing regular, up-to-date information on a patient's condition and progress, VF tests at home may improve outcomes. The investigators also foresee the benefits of this app on NHS clinical services, with the potential of reduced outpatient appointments and waiting times thus easing pressure on the NHS.
Looking for future studies?
Notify Me17 year and older
All sexes
Observational
Southampton, SO16 6YD, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this study, the investigators aim to teach the participants to use the the visualFields easy App . The investigators will be using the app in the clinic with the patients watching, demonstrating its use and discussing and explaining its functions. Having observed how to use the application, the participant will then complete the visual field assessment.
Time frame: Through study completion, an average of 1 year
To determine the statistical strength and / or presence or absence of correlation between the iPad-based visual field assessment procedure in comparison to clinic-based visual field assessment.
Time frame: Through study completion, an average of 1 year
To explore through a quantitative questionnaire, the possible feasibility and utility of home-based visual field assessment
University Hospital Southampton NHS Foundation Trust
Other
Accuracy and Feasibility of Visual Field Screening Apps - the visualFields Easy App
Acronym: VISA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04175444
Visual Field Defect, Peripheral
Nashville, Tennessee, United States
View Trial DetailsNCT03797469
Eye Diseases, Glaucoma
New York, United States
View Trial DetailsNCT04786886
Visual Field Defect, Nasal Step, Visual Field Defect, Paracentral Scotoma of Both Eyes
Miami, Florida, United States
View Trial DetailsNCT05141604
Blindness, Eye Diseases
Boston, Massachusetts, United States
View Trial Details